Concepcion Rodriguez-Fernandez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Journal: Blood advances
Published: October 29, 2025

Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms Predisposition.

Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms Predisposition.

Journal: Blood advances
Published: October 29, 2025

Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC).

Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC).

Journal: HemaSphere
Published: May 06, 2025

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Journal: HemaSphere
Published: July 11, 2024

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.

Journal: Cancers
Published: December 09, 2023

Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at Diagnosis.

Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at Diagnosis.

Journal: Cancers
Published: July 21, 2023

Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutation.

Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutation.

Journal: International journal of laboratory hematology
Published: March 21, 2023

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.

Journal: Leukemia
Published: July 07, 2022

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma.

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma.

Journal: Blood advances
Published: June 22, 2022

Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy.

Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy.

Journal: Blood advances
Published: May 16, 2022

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Journal: Blood advances
Published: February 17, 2022

Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma.

Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma.

Journal: Cancers
Published: January 14, 2022
Showing 1-12 of 32

Last Updated: 09/26/2026